HDAC6 Promotes Cardiac Fibrosis Progression through Suppressing RASSF1A Expression

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Epigenetics

Background:

• Cardiac fibrosis, marked by extracellular matrix accumulation, impairs heart function.
• Histone deacetylase 6 (HDAC6) is implicated in cellular processes but its role in cardiac fibrosis is unclear.

Purpose of the Study:

• To elucidate the role of HDAC6 in cardiac fibrosis progression.
• To investigate the molecular mechanisms by which HDAC6 influences cardiac fibroblast behavior.

Main Methods:

• Cardiac fibrosis was induced in Sprague-Dawley rats.
• HDAC6 expression and its effects on cardiac fibroblasts were analyzed using Western blotting, qRT-PCR, and siRNA.
• RASSF1A/ERK1/2 signaling pathways were examined.

Main Results:

• HDAC6 was upregulated in cardiac fibrosis tissues and activated fibroblasts.
• HDAC6 inhibition reduced myofibroblast markers and fibroblast proliferation.
• HDAC6 knockdown or inhibition increased RASSF1A expression.

Conclusions:

• HDAC6 inactivation of RASSF1A is a novel mechanism controlling cardiac fibroblast proliferation.
• Targeting HDAC6 may offer a therapeutic strategy for cardiac fibrosis.